PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+5.72%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.4B
AUM Growth
+$1.4B
(-3%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-9.15%
Top 10 Holdings %
Top 10 Hldgs %
38.07%
Holding
267
New
41
Increased
25
Reduced
70
Closed
46
Top Buys
| 1 |
ATAI Life Sciences
ATAI
|
$23.2M |
| 2 |
Agilon Health
AGL
|
$15.6M |
| 3 |
Privia Health
PRVA
|
$15.4M |
| 4 |
Eli Lilly
LLY
|
$15.1M |
| 5 |
Lantheus
LNTH
|
$14.8M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$23.9M |
| 2 |
Vericel Corp
VCEL
|
$20.8M |
| 3 |
Align Technology
ALGN
|
$19M |
| 4 |
SI-BONE Inc
SIBN
|
$17.5M |
| 5 |
STAAR Surgical
STAA
|
$16.8M |
Sector Composition
| 1 | Healthcare | 79.46% |
| 2 | Industrials | 3.16% |
| 3 | Materials | 1.25% |
| 4 | Financials | 1.11% |
| 5 | Consumer Staples | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
76
DELISTED
Immunogen Inc
IMGN
| $4.54M | 0.14% | 689,049 -115,143 | -14% | -$759K |
|
77
Lyra Therapeutics
LYRA
$11.5M
| $4.36M | 0.14% | +542,644 | New | +$4.36M |
|
|
OMIC
78
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $4.29M | 0.13% | +156,074 | New | +$4.29M |
|
79
Milestone Pharmaceuticals
MIST
$156M
| $3.86M | 0.12% | 702,545 +234,905 | +50% | +$1.29M |
|
|
VERV
80
DELISTED
Verve Therapeutics
VERV
| $3.58M | 0.11% | +59,393 | New | +$3.58M |
|
81
Celldex Therapeutics
CLDX
$1.47B
| $3.51M | 0.11% | 105,056 -58,559 | -36% | -$1.96M |
|
82
Beam Therapeutics
BEAM
$1.66B
| $3.22M | 0.1% | +25,000 | New | +$3.22M |
|
83
Arcutis Biotherapeutics
ARQT
$1.86B
| $3.11M | 0.1% | 114,061 -31,683 | -22% | -$865K |
|
84
Doximity
DOCS
$12.7B
| $2.91M | 0.09% | +50,000 | New | +$2.91M |
|
|
VINC
85
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $2.78M | 0.09% | 214,033 +64,517 | +43% | +$838K |
|
|
LHDX
86
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $2.66M | 0.08% | +400,000 | New | +$2.66M |
|
87
Senti Biosciences
SNTI
$38.5M
| $2.49M | 0.08% | +250,000 | New | +$2.49M |
|
88
Arvinas
ARVN
$568M
| $2.43M | 0.08% | 31,543 -474 | -1% | -$36.5K |
|
|
ABGI
89
DELISTED
ABG Acquisition Corp. I Class A Ordinary Shares
ABGI
| $2.38M | 0.07% | 242,770 -3,737 | -2% | -$36.6K |
|
90
Monte Rosa Therapeutics
GLUE
$296M
| $2.27M | 0.07% | +100,000 | New | +$2.27M |
|
91
Forte Biosciences
FBRX
$137M
| $2.21M | 0.07% | 65,583 -47,883 | -42% | -$1.61M |
|
|
FRONU
92
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $2.17M | 0.07% | 216,708 -83,292 | -28% | -$833K |
|
|
FVAM
93
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
| $2.15M | 0.07% | 215,836 -3,300 | -2% | -$32.9K |
|
94
Venus Concept
VERO
$4.11M
| $2.14M | 0.07% | 686,874 -14,612 | -2% | -$45.4K |
|
95
Novavax
NVAX
$1.21B
| $2.12M | 0.07% | +10,000 | New | +$2.12M |
|
96
Nautilus Biotechnolgy
NAUT
$85.9M
| $2.09M | 0.07% | 207,079 -88,475 | -30% | -$893K |
|
97
Kura Oncology
KURA
$686M
| $2.08M | 0.06% | 99,862 -24,378 | -20% | -$508K |
|
98
Cyclerion Therapeutics
CYCN
$7.91M
| $1.98M | 0.06% | +507,489 | New | +$1.98M |
|
99
Greenlane Holdings
GNLN
$4.71M
| $1.82M | 0.06% | 407,905 | – | – |
|
|
PMGMU
100
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
| $1.61M | 0.05% | 161,472 -50,000 | -24% | -$498K |
|